Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

Infectious disease

Covid-19

Regeneron offers early look at COVID-19 antibody cocktail data

The drug appears to lower viral load in a subset of patients, but its use could be limited

by Lisa M. Jarvis , Megha Satyanarayana
September 30, 2020 | A version of this story appeared in Volume 98, Issue 38

Article:

This article has been sent to the following recipient: